Molecular Products

Harlow, United Kingdom Founded: 1924 • Age: 102 yrs Acquired By Filtration Group
Products for pollutant gas filtration are manufactured and distributed.

About Molecular Products

Molecular Products is a company based in Harlow (United Kingdom) founded in 1924, and was acquired by Filtration Group in June 2021. Products for pollutant gas filtration are manufactured and distributed. Molecular Products has raised $6.54 million across 1 funding round from investors including Filtration Group, BGF and Arlington Capital Partners. Molecular Products has completed 1 acquisition, including OC Lugo. Its chief executive, as recorded, is Troy Rhudy. Molecular Products offers products and services including Sofnolime and Impregnated Activated Carbons. Its legal entity is Molecular Products Inc.

Company details

Molecular Products was established in 1924 and is headquartered in Harlow, United Kingdom. Operations are centered in the manufacturing sector, where filtration products for pollutant gases are developed and produced. These solutions are applied across industrial settings to address gas purification needs. The company is led by CEO Troy Rhudy, with activities spanning product innovation and supply to global markets.

  • Headquarters Harlow, United Kingdom
  • Stage Acquired
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website molecularproducts.com
  • Social LinkedIn X
  • Acquired by Filtration Group (Jun 2021)
  • Legal Name Molecular Products Inc
Key Metrics

Products & Services of Molecular Products

Molecular Products offers a comprehensive portfolio of products and services, including Sofnolime and Impregnated Activated Carbons.

Sofnolime
CO2 Absorbents

Sofnolime is utilized as a carbon dioxide absorbent in diving and hyperbaric systems to maintain breathable atmospheres in sealed environments.

Impregnated Activated Carbons
Air Purification

These are manufactured for critical air purification in industrial, defense, and nuclear applications to ensure the removal of harmful emissions.

Funding Insights of Molecular Products

Molecular Products has successfully raised a total of $6.54M through 1 strategic funding round. The most recent funding activity was a Series B round of $6.54 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $6.54M
  • Total Rounds 1
  • Last Round Series B β€” $6.54M
  • First Round $6.54M

    (Sep 2014)

  • Investors Count 1

All 1 funding rounds of Molecular Products with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2014$6.54MSeries B––
Valuation history

3 investors in total: 3 institutional.

Investors in Molecular Products

Molecular Products has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Filtration Group, BGF and Arlington Capital Partners.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Early & Growth stage tech & offline focused VC firm funding companies in the UK & Ireland
bgf.co.ukBelfast, United Kingdom
Private equity firm focused on investments in regulated industries.
arlingtoncap.com
Filtration products and solutions are manufactured for diverse industries.
1942filtrationgroup.comAustin, United States
Premium access

Investor details for Molecular Products

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Molecular Products

16 people are tracked at Molecular Products (8 in leadership, 8 in team).

NameRoleGroup
Troy Rhudy
CEOLeadership
Paul Flowers
Managing DirectorLeadership
Lisa Keilthy Fcma
Director Of FinanceLeadership
Brandon Smith
Chief Financial OfficerLeadership
Joseph Carloto
Chief Financial Officer/operating PartnerLeadership
Vikrant Patil
Country Head - India.Leadership
Mark Jarvis
Director Of EngineeringLeadership
Ruben C.
Director Of Quality Assurance And Regulatory AffairsLeadership
Tony de Viveiros de M. Franca
Quality Control Laboratory ManagerTeam
Kevin B. McBride
Financial ControllerTeam
Mohamed Kasmani
Financial ControllerTeam
Jessica A.
Senior AccountantTeam
Joseph P. Ciccone
Soda Lime Expert & Op-cat DabblerTeam
Natalie Gorton
Chemical EngineerTeam
Matt Boucher
Plant ManagerTeam
Justin Rogers
Line ManagerTeam
Premium access

Complete people profiles for Molecular Products

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Molecular Products

Molecular Products has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OC Lugo.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
RG and transition metal catalysts are manufactured by the company.
oclugo.comNyack, United States1973Nov 2019β€’β€’β€’β€’
Premium access

Complete acquisition details for Molecular Products

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Molecular Products

5 dated milestones of Molecular Products across 97 years, from founding to its latest funding, stage changes and deals.

  1. Founded Molecular Products is founded.
  2. Funding First funding round of $6.5M.
  3. Exit Acquired by Arlington Capital Partners.
  4. Acquisition Acquires OC Lugo.
  5. Exit Acquired by Filtration Group.

Web traffic of Molecular Products

The website of Molecular Products (molecularproducts.com) receives about 4.2K visits a month.

  • Monthly visits
    4.2K

    ▼ 27% vs previous month

Similar websites

Websites whose visitors overlap most with Molecular Products. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
minearc.com
minearc.com
100%
#1,534,944–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Molecular Products

Molecular Products was founded in 1924 and raised its 1st funding round 90 years after it was founded.

Molecular Products is headquartered in Harlow, United Kingdom. It is registered at Harlow, Essex, United Kingdom.

Troy Rhudy is the CEO of Molecular Products, as recorded in our data.

Molecular Products is a funded company, having raised a total of $6.54M across 1 funding round to date. The company's 1st funding round was a Series B of $6.54M, raised on Sep 2014.

Molecular Products was established in 1924 and is headquartered in Harlow, United Kingdom. Operations are centered in the manufacturing sector, where filtration products for pollutant gases are developed and produced. These solutions are applied across industrial settings to address gas purification needs. The company is led by CEO Troy Rhudy, with activities spanning product innovation and supply to global markets.

Molecular Products offers Sofnolime and Impregnated Activated Carbons.

Molecular Products has made 1 acquisition, including OC Lugo.

Molecular Products has 3 investors. Key investors include Filtration Group, BGF, and Arlington Capital Partners.

Molecular Products operates through Molecular Products Inc.

Yes. Molecular Products was acquired by Filtration Group in June 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available